What's Going On With Bionano Genomics Stock?
Portfolio Pulse from Erica Kollmann
Bionano Genomics, Inc. (NASDAQ:BNGO) shares are trading lower after the company commenced trading on a 1-for-10 reverse stock split-adjusted basis. The company's shares are moving lower on above-average trading volume with more than 660,000 shares traded compared to the 100-day average of 1.04 million shares. Bionano Genomics is expected to release its Q2 financial reports on Wednesday, with an expected loss of 10 cents per share and revenue of $8.29 million.
August 07, 2023 | 2:08 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bionano Genomics shares are trading lower after a 1-for-10 reverse stock split. The company is expected to release its Q2 financial reports on Wednesday.
The company's shares are trading lower after the announcement of a 1-for-10 reverse stock split, which typically indicates a company's attempt to boost its share price. The upcoming Q2 financial reports could further impact the stock price depending on the results.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100